176 related articles for article (PubMed ID: 9013396)
1. Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism.
Naumann M; Götz M; Reiners K; Lange KW; Riederer P
J Neural Transm (Vienna); 1996; 103(8-9):1083-91. PubMed ID: 9013396
[TBL] [Abstract][Full Text] [Related]
2. Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.
Assmann B; Köhler M; Hoffmann GF; Heales S; Surtees R
Pediatr Res; 2002 Jul; 52(1):91-4. PubMed ID: 12084853
[TBL] [Abstract][Full Text] [Related]
3. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia.
Tabaddor K; Wolfson LI; Sharpless NS
Neurology; 1978 Dec; 28(12):1254-8. PubMed ID: 569784
[TBL] [Abstract][Full Text] [Related]
4. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid.
Hill KK; West SA; Ekhator NN; Bruce AB; Wortman MD; Baker DG; Geracioti TD
Neurosci Lett; 1999 Nov; 276(1):25-8. PubMed ID: 10586966
[TBL] [Abstract][Full Text] [Related]
5. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.
Hibbeln JR; Linnoila M; Umhau JC; Rawlings R; George DT; Salem N
Biol Psychiatry; 1998 Aug; 44(4):235-42. PubMed ID: 9715354
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population.
Hyland K; Surtees RA; Heales SJ; Bowron A; Howells DW; Smith I
Pediatr Res; 1993 Jul; 34(1):10-4. PubMed ID: 7689195
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
8. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
Stanley M; Traskman-Bendz L; Dorovini-Zis K
Life Sci; 1985 Oct; 37(14):1279-86. PubMed ID: 2413327
[TBL] [Abstract][Full Text] [Related]
9. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.
Inagawa T; Ishikawa S; Uozumi T
J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788
[TBL] [Abstract][Full Text] [Related]
10. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
[No Abstract] [Full Text] [Related]
11. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
[TBL] [Abstract][Full Text] [Related]
12. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
13. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
14. [Homovanillic (HVA) and 5-hydroxyindoleacetic (5-HIAA) acid concentration in the cerebrospinal fluid of patients with supratentorial tumors and symptoms of intracranial hypertension (preliminary report)].
Majchrzak H; Kmieciak-Kołada K; Herman Z; Wencel T
Neurol Neurochir Pol; 1980; 14(1):87-90. PubMed ID: 6154903
[TBL] [Abstract][Full Text] [Related]
15. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs.
Reisner IR; Mann JJ; Stanley M; Huang YY; Houpt KA
Brain Res; 1996 Apr; 714(1-2):57-64. PubMed ID: 8861609
[TBL] [Abstract][Full Text] [Related]
17. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
[No Abstract] [Full Text] [Related]
18. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
Massarotti M; Migliore A; Roccella P; Toffano G
Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
[No Abstract] [Full Text] [Related]
19. Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
Willemse J; van Nieuwenhuizen O; Gooskens RH; Westenberg HG
Neuropediatrics; 1984 Oct; 15(4):208-10. PubMed ID: 6208504
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
Brashear A; Butler IJ; Hyland K; Farlow MR; Dobyns WB
Ann Neurol; 1998 Apr; 43(4):521-6. PubMed ID: 9546335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
